195 related articles for article (PubMed ID: 33552061)
21. Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disorders.
Krause S; Kuckelkorn U; Dörner T; Burmester GR; Feist E; Kloetzel PM
Ann Rheum Dis; 2006 Aug; 65(8):1021-7. PubMed ID: 16414974
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of immunoproteasome subunit low molecular mass polypeptide 7 with ONX-0914 improves hypoxic-ischemic brain damage via PI3K/Akt signaling.
Zhou Y; Gou Z; Huang L; Fan Y; Zhang F; Lu L
Neuroreport; 2021 Oct; 32(14):1206-1215. PubMed ID: 34406990
[TBL] [Abstract][Full Text] [Related]
23. T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens.
Caudill CM; Jayarapu K; Elenich L; Monaco JJ; Colbert RA; Griffin TA
J Immunol; 2006 Apr; 176(7):4075-82. PubMed ID: 16547243
[TBL] [Abstract][Full Text] [Related]
24. Anti-viral immune response in the lung and thymus: Molecular characterization and expression analysis of immunoproteasome subunits LMP2, LMP7 and MECL-1 in pigs.
Liu Q; Hu W; Zhang YL; Hu SP; Zhang Z; He XJ; Cai XH
Biochem Biophys Res Commun; 2018 Aug; 502(4):472-478. PubMed ID: 29856997
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the Immunoproteasome Subunit LMP7 with ONX 0914 Ameliorates Graft-versus-Host Disease in an MHC-Matched Minor Histocompatibility Antigen-Disparate Murine Model.
Zilberberg J; Matos J; Dziopa E; Dziopa L; Yang Z; Kirk CJ; Assefnia S; Korngold R
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1555-64. PubMed ID: 26093043
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-37 reduces inflammation and impairs phagocytosis of platelets in immune thrombocytopenia (ITP).
Zhao Y; Ni X; Xu P; Liu Q; Sun T; Liu X; Ji X; Qiu J; Li J; Wang S; Han P; Peng J; Hou M; Li G
Cytokine; 2020 Jan; 125():154853. PubMed ID: 31557634
[TBL] [Abstract][Full Text] [Related]
27. The immunoproteasome inhibitor ONX-0914 regulates inflammation and expression of contraction associated proteins in myometrium.
Liong S; Lim R; Nguyen-Ngo C; Barker G; Parkington HC; Lappas M
Eur J Immunol; 2018 Aug; 48(8):1350-1363. PubMed ID: 29883518
[TBL] [Abstract][Full Text] [Related]
28. Inhibiting the immunoproteasome exacerbates the pathogenesis of systemic Candida albicans infection in mice.
Mundt S; Basler M; Buerger S; Engler H; Groettrup M
Sci Rep; 2016 Jan; 6():19434. PubMed ID: 26776888
[TBL] [Abstract][Full Text] [Related]
29. Proteasome or immunoproteasome inhibitors cause apoptosis in human renal tubular epithelial cells under normoxic and hypoxic conditions.
Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Int Urol Nephrol; 2016 Jun; 48(6):907-15. PubMed ID: 26920131
[TBL] [Abstract][Full Text] [Related]
30. The proteasome activator REGγ counteracts immunoproteasome expression and autoimmunity.
Yao L; Zhou L; Xuan Y; Zhang P; Wang X; Wang T; Meng T; Xue Y; Ma X; Shah AS; Shang S; Ma X; Xie W; Wang H; Fu Q; Xia Y; Moses RE; Wang H; Li L; Xiao J; Zhang B; Li X
J Autoimmun; 2019 Sep; 103():102282. PubMed ID: 31171475
[TBL] [Abstract][Full Text] [Related]
31. Neuronal induction of the immunoproteasome in Huntington's disease.
Díaz-Hernández M; Hernández F; Martín-Aparicio E; Gómez-Ramos P; Morán MA; Castaño JG; Ferrer I; Avila J; Lucas JJ
J Neurosci; 2003 Dec; 23(37):11653-61. PubMed ID: 14684867
[TBL] [Abstract][Full Text] [Related]
32. Noncytotoxic Inhibition of the Immunoproteasome Regulates Human Immune Cells In Vitro and Suppresses Cutaneous Inflammation in the Mouse.
Ah Kioon MD; Pierides M; Pannellini T; Lin G; Nathan CF; Barrat FJ
J Immunol; 2021 Apr; 206(7):1631-1641. PubMed ID: 33674446
[TBL] [Abstract][Full Text] [Related]
33. Immunoproteasome inhibitor DPLG3 attenuates experimental colitis by restraining NF-κB activation.
Moallemian R; Rehman AU; Zhao N; Wang H; Chen H; Lin G; Ma X; Yu J
Biochem Pharmacol; 2020 Jul; 177():113964. PubMed ID: 32278007
[TBL] [Abstract][Full Text] [Related]
34. Immunoproteasome inhibition prevents progression of castration-resistant prostate cancer.
Li J; Liu N; Zhou H; Xian P; Song Y; Tang X; Li Y; Basler M
Br J Cancer; 2023 Mar; 128(7):1377-1390. PubMed ID: 36681728
[TBL] [Abstract][Full Text] [Related]
35. Mouse immune thrombocytopenia is associated with Th1 bias and expression of activating Fcγ receptors.
Nishimoto T; Okazaki Y; Numajiri M; Kuwana M
Int J Hematol; 2017 May; 105(5):598-605. PubMed ID: 28028748
[TBL] [Abstract][Full Text] [Related]
36. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.
Min YN; Wang CY; Li XX; Hou Y; Qiu JH; Ma J; Shao LL; Zhang X; Wang YW; Peng J; Hou M; Shi Y
J Thromb Haemost; 2016 Mar; 14(3):559-71. PubMed ID: 26749059
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood-brain barrier injury through the Wnt/β-catenin signalling pathway.
Chen XY; Wan SF; Yao NN; Lin ZJ; Mao YG; Yu XH; Wang YZ
Mil Med Res; 2021 Dec; 8(1):62. PubMed ID: 34857032
[TBL] [Abstract][Full Text] [Related]
38. High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcgamma receptors on monocytes in patients with primary immune thrombocytopenia.
Liu XG; Ma SH; Sun JZ; Ren J; Shi Y; Sun L; Dong XY; Qin P; Guo CS; Hou M; Peng J
Blood; 2011 Feb; 117(6):2061-9. PubMed ID: 21131591
[TBL] [Abstract][Full Text] [Related]
39. Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies.
Bandoh N; Ogino T; Cho HS; Hur SY; Shen J; Wang X; Kato S; Miyokawa N; Harabuchi Y; Ferrone S
Tissue Antigens; 2005 Sep; 66(3):185-94. PubMed ID: 16101829
[TBL] [Abstract][Full Text] [Related]
40. Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activation.
Bitzer A; Basler M; Krappmann D; Groettrup M
Mol Immunol; 2017 Mar; 83():147-153. PubMed ID: 28157553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
